Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy

HIV/HBV coinfection in children and antiviral therapy

“…The response rate to a repeat HBV immunization series was 17% after the first vaccine, 82.5% after the second and 92% after the third [60]. After 3 years, 71% of these children maintained protective anti-HBsAg antibody levels, suggesting that HIV-infected children will benefit from a repeat HBV vaccine series after initiation of cART [61]. …”

Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infection

“…We excluded 43 studies some of which were non-randomised (Abzug 2009; Alaei 2003; Bailey 2008; Carne 1987; Horster 2010; Kalinowska-Nowak 2007; Koblin 1999; Lao-Araya 2011; Loke 1990; Paitoonpong 2008; Sellar 2009; Thaithumyanon 2002; Wilson 2001; Wursthorn 2011), not in PLHIV (Altuntas 2011; Mehta 2010; Mehta 2010a; Miller 1989; Odaka 1988; Pasricha 2005; Thompson 1998) testing adjuvants to hepatitis B vaccine (Cooper 2005a; Cooper 2008; Overton 2010; Overton 2011; Sasaki 2003; Sayad 2012); testing modalities of administering hepatitis B vaccine (Bunupuradah 2011; de Vries-Sluijs 2011; Flynn 2011; Fonseca 2005; Hwang 2010; Launay 2011; McQuillan 2010) vaccines targeting other conditions (Johnson 1999; Kintu 2013; Launay 2011a). See Characteristics of excluded studies.…”

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children

“…33 The American Academy of Pediatrics Committee on Infectious Disease recommends annual anti-HBs testing and booster doses when the anti-HBs levels decline to <10 mIU/mL for hemodialysis patients and other immunocompromised people at continued risk of hepatitis B infection (CIII) . 34 HBV-infected children should be advised not to share toothbrushes or other personal-care articles that might be contaminated with blood (e.g., razors, tweezers, nail clippers) and to cover open or draining wounds.…”